Finance

Beta
Lists
RVU:WSE
Ryvu Therapeutics SA
PLN 14.20
-0.56%
(-0.080) 1D
Jun 5, 5:04:19 PM GMT+2  ·   PLN
All symbols
SymbolPriceChange% Change
Generating top insights for RVU...
Open
PLN 14.30
High
PLN 14.70
Low
PLN 14.20
Mkt. cap
328.31M
Avg. vol.
55.60K
Volume
66.43K
52-wk high
PLN 32.50
52-wk low
PLN 13.64
EPS
-PLN 3.83
Shares outstanding
23.12M
No. of employees
228
Open
PLN 14.30
High
PLN 14.70
Low
PLN 14.20
Mkt. cap
328.31M
Avg. vol.
55.60K
Volume
66.43K
52-wk high
PLN 32.50
52-wk low
PLN 13.64
EPS
-PLN 3.83
Shares outstanding
23.12M
No. of employees
228
News stories
From sources across the web
About Ryvu Therapeutics SA
CEO-
Employees228
Founded2007
Headquarters-
SectorHealth care
Websiteryvu.com
Last report
May 21, 2026
Fiscal period
Q1 2026
EPS / Est. (PLN)
-PLN 0.48 / -
0.00%miss
Revenue / Est. (PLN)
21.71M / 23.27M
-6.69%miss
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in PLN
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in PLN
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-48.76M
19.50M
25.78M
21.71M
Cost of goods sold
-11.01M
3.64M
4.08M
4.13M
Cost of revenue
-11.01M
3.64M
4.08M
4.13M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
25.60M
36.29M
34.87M
26.59M
Operating expense
17.52M
41.28M
38.50M
29.99M
Total operating expenses
6.51M
44.92M
42.58M
34.12M
Operating income
-55.27M
-25.42M
-16.80M
-12.41M
Other non operating income
6.47M
1.54M
401.00K
2.67M
EBT including unusual items
-57.36M
-24.71M
-17.52M
-12.47M
EBT excluding unusual items
-46.99M
-24.73M
-17.46M
-12.71M
Income tax expense
585.00K
-
71.00K
180.00K
Effective tax rate
-1.02%
-
-0.41%
-1.44%
Other operating expenses
-65.00K
1.44M
4.33M
1.25M
Net income
-57.95M
-24.71M
-17.59M
-12.65M
Net profit margin
118.84%
-126.73%
-68.22%
-58.25%
Earnings per share
-
-
-
-
Interest and investment income
2.90M
1.28M
891.00K
-
Interest expense
-1.96M
-2.06M
-2.10M
-2.97M
Net interest expenses
933.00K
-775.00K
-1.21M
-2.97M
Depreciation and amortization charges
-9.13M
2.86M
1.87M
2.15M
EBITDA
-38.55M
-22.90M
-15.15M
-10.26M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer